查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1820452

2025 年至 2033 年化學資訊學市場規模、佔有率、趨勢及按應用和地區分類的預測

Chemoinformatics Market Size, Share, Trends and Forecast by Application, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球化學資訊學市場規模為 68 億美元。展望未來， IMARC Group估計到 2033 年市場規模將達到 131.2 億美元，2025 年至 2033 年的複合年成長率為 7.58%。北美目前佔據市場主導地位，2024 年市佔率將超過 43.6%。全球市場受到以下因素的驅動：藥物發現需求的不斷成長、慢性病患病率的不斷上升、人工智慧 (AI)、機器學習 (ML)、巨量資料分析的進步、個人化醫療需求的不斷成長、研發 (R&D) 投資的增加、戰略性產業合作以及製藥、生物技術和學術研究領域的應用不斷擴大。

全球化學資訊學市場的成長主要得益於對高效藥物發現和開發流程日益成長的需求，而這又得益於個人化醫療需求的不斷成長。此外，計算化學、機器學習和巨量資料分析領域的技術進步正在改善分子建模和虛擬篩選，並加快研究進度，從而促進市場發展。此外，製藥和生技公司對研發計畫的投入不斷增加，也推動了市場成長。例如，根據行業報告，一項針對 130 多名生物技術高管的調查顯示，60% 的生物技術公司打算增加研發支出，而只有 2% 的公司預計會削減支出。儘管受訪者對產品的成功持樂觀態度，但 32% 的受訪者認為臨床試驗的複雜性是該領域面臨的最大障礙。該報告還揭露了融資策略，48% 的受訪者採用了製藥合作夥伴關係，而 32% 的受訪者採用了風險投資。因此，策略性外包和合作對於最大限度地促進臨床開發和吸引投資都至關重要。政府針對創新醫療保健解決方案的舉措以及學術機構和行業參與者之間的合作正在進一步擴大化學資訊學工具的應用，從而促進全球市場擴張。

美國化學資訊學市場的需求是由藥物發現和開發的持續進步所驅動的，而這種進步又受到個人化醫療和精準治療需求成長的刺激。包括癌症和神經系統疾病在內的慢性病盛行率不斷上升，迫使製藥公司加快研究進程，增加了化學資訊工具的需求。例如，2024 年 3 月 14 日，《刺胳針神經病學》發表的一項研究報告稱，2021 年全球有超過 30 億人患有神經系統疾病。這些疾病已經超過所有其他原因，成為導致疾病和殘疾的最大促進因素，自 1990 年以來，目前導致相關的傷殘調整生命年 (DALY) 增加了 18%。超過 80% 的神經系統死亡和健康損失發生在中低收入國家，從而引起人們對醫療保健取得的巨大不平等的關注。人工智慧和巨量資料分析的整合正在簡化分子建模和化合物分析，這進一步推動了市場的成長。此外，政府支持數位醫療轉型的措施和增加研發投資正在促進創新，從而擴大市場。

化學資訊學市場趨勢：

人工智慧和機器學習整合的成長

人工智慧 (AI) 與機器學習 (ML) 的融合正在加快化學研發活動的速度，並改變化學資訊學的市場趨勢。產業報告顯示，AI 和 ML 技術可將藥物發現的時間縮短高達 50%，從而加快識別有用化合物所需的時間。用於預測分子特性等的 AI 模型使研究人員能夠以前所未有的速度和精度模擬化學反應並分析資料。這可以透過最少的反覆試驗來加快研究速度。事實證明，使用 AI 驅動的化學資訊學工具可以將研究相關成本降低約 40%，使其成為製藥和學術研究機構急需的工具。這些進步也提高了藥物發現和材料開發的效率，從而創新了新產品，並有可能催生醫療方法、材料和技術，從而推動該市場在未來幾年的快速成長。

藥物研發應用的興起

化學資訊學正逐漸成為藥物研發的關鍵領域之一，其工具擴大用於分析分子結構和預測生物活性。事實上，根據一份產業報告，超過75%的新藥研發目前使用化學資訊學工具進行分子分析、化合物篩選和毒性預測。這一趨勢使得過去五年藥物研發中應用的計算方法成長了60%。這些工具能夠預測分子相互作用並最佳化先導化合物，從而在更短的時間內識別出有潛力的候選藥物。化學資訊學還可以透過減少昂貴且耗時的實驗室實驗來加快藥物研發進程。隨著數據驅動的藥物研發發展，化學資訊學的需求將不斷成長，從而為製藥公司提供以最低成本進行高效藥物研發的能力，確保患者獲得更好的治療效果，並提升化學資訊學的市場前景。

擴大採用基於雲端的平台

雲端平台正在改變研究機構和製藥公司部署和使用化學資訊學工具的運作模式。據業界報告稱，雲端技術的採用加快了化學資料的處理速度。雲端基礎設施提供的靈活性和可擴展性使研究人員能夠儲存和處理大型資料集、促進遠端協作，並可使用複雜的化學資訊學工具，而無需在現場建立大型基礎設施。 Avaahi Tech 的 2024 年報告顯示，製藥公司透過採用雲端服務平均降低了 30% 的 IT 營運成本，從而實現了更有效率、更具成本效益的研究和營運。一般來說，雲端運算還支援跨學科更輕鬆的資料共享和協作，從而促進創新。隨著雲端平台的不斷變化，它們在加速研究和實現藥物開發突破方面發揮越來越重要的作用，尤其是在高通量環境中。

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 二手資料
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

第5章：全球化學資訊學市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依應用

  • 化學分析
  • 藥物研發
  • 藥物驗證
  • 其他

第7章：市場區隔：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第 8 章：SWOT 分析

第9章：價值鏈分析

第 10 章：波特五力分析

第 11 章：價格分析

第 12 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Agilent Technologies Inc.
    • Bio-Rad Laboratories Inc.
    • BioSolveIT GmbH
    • BIOVIA (Dassault Systemes)
    • ChemAxon Inc.
    • Eurofins CEREP SA (Eurofins Panlabs Inc.)
    • Jubilant Biosys Inc.
    • Molecular Discovery Ltd.
    • OpenEye Scientific Software Inc.
    • Schrodinger Inc.
Product Code: SR112025A3928

The global chemoinformatics market size was valued at USD 6.80 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 13.12 Billion by 2033, exhibiting a CAGR of 7.58% from 2025-2033. North America currently dominates the market, holding a significant market share of over 43.6% in 2024. The global market is driven by rising demand for drug discovery, increasing prevalence of chronic diseases, advancements in artificial intelligence (AI), machine learning (ML), big data analytics, growing need for personalized medicine, increased research and development (R&D) investments, strategic industry collaborations, and expanding applications in pharmaceutical, biotechnology, and academic research sectors.

The global chemoinformatics market growth is majorly driven by the increasing need for efficient drug discovery and development processes, fueled by rising demand for personalized medicine. Moreover, ongoing technological advancements in computational chemistry, ML, and big data analytics are improving molecular modeling and virtual screening, accelerating research timelines, thereby fostering the market. Additionally, growing investments from pharmaceutical and biotechnology companies into R&D initiatives are propelling market growth. For instance, as per industry reports, a survey of +130 biotech executives revealed that 60% of biotechs intend to increase their R&D spending, whereas only 2% expect cuts. Even though respondents were optimistic about the success of products, 32% named the complexity of clinical trials as the most significant obstacle in the segment. Funding strategies were also exposed in the report, and 48% used pharmaceutical partnerships while 32% used venture capital. Therefore, both strategic outsourcing and collaboration proved important to maximize clinical development and attract investment. Government initiatives for innovative healthcare solutions and collaborations between academic institutions and industry players are further expanding the adoption of chemoinformatics tools, which in turn is fostering market expansion globally.

The United States chemoinformatics market demand is driven by ongoing advancements in drug discovery and development spurred by the increase in demand for personalized medicine and precision therapeutics. A rising prevalence of chronic diseases, including cancers and neurological disorders, is compelling pharmaceutical companies to speed up the research processes that have increased the demand for chemoinformatics tools. For instance, on 14 March 2024, a study published in The Lancet Neurology reported that in 2021 more than 3 billion people worldwide were living with neurological conditions. The conditions have surpassed all other causes to become the largest driver of illness and disability and currently account for an increase of 18% more associated disability-adjusted life years (DALYs) since 1990. More than 80% of neurological deaths and health losses happen in low- and middle-income countries, thereby calling attention to major inequalities in accessing healthcare. Integration of AI and big data analytics is streamlining molecular modeling and compound analysis, which further propels the growth of the market. Furthermore, government initiatives supporting digital healthcare transformation and increased investments in R&D are fostering innovation, thereby expanding the market.

Chemoinformatics Market Trends:

Growth in AI and Machine Learning Integration

The integration of AI and ML is enhancing the speed of chemical R&D activities, transforming the chemoinformatics market trends. Industrial reports show that AI and ML technology reduce the timeline of drug discovery by up to 50%, thereby accelerating how long it takes to identify useful compounds. AI models, such as those used to predict molecular properties, enable researchers to simulate chemical reactions and analyze data with unprecedented speed and accuracy. This leads to faster research through minimal trial and error. With AI-driven chemoinformatics tools, research has been proven to reduce the costs associated with it by about 40%, making it a much-needed tool for pharmaceutical and academic research institutions. These advancements are also improving the efficacy of drug discovery as well as material development, and thereby innovating new products, potentially giving rise to medical treatments, materials, and technology, thereby resulting in the rapid growth of this market in the coming years.

Rise in Drug Discovery Applications

Chemoinformatics is progressively becoming one of the key areas in drug discovery, with tools that are increasingly used in analyzing molecular structures and predicting biological activity. In fact, according to an industrial report, more than 75% of new drug discoveries now use the tools of chemoinformatics for molecular analysis, compound screening, and predictions of toxicity. This trend has made it increased by 60% to the computation methods applied in drug discovery in the last five years. These tools have the capability of identifying promising candidates for drugs with a much shorter period due to predictions in molecular interactions and optimization of lead compounds. Chemoinformatics also serves to speed up the drug development process by lessening the costly and time-consuming lab experiments involved. Further ahead with the data-driven evolvement of drug discovery, the role of chemoinformatics would be more in demand and growing, thereby providing pharmaceuticals the capacity for an efficient drug development process with minimal cost, ensuring a better outcome for patients and enhancing the chemoinformatics market outlook.

Increasing Adoption of Cloud-based Platforms

Cloud-based platforms are changing the mode of operation for chemoinformatics tool deployment and accessibility among research institutes and pharmaceutical firms. According to industrial reports, the adoption of cloud has quickened the processing of chemical data. The agility and scalability offered by cloud infrastructure enable researchers to store and process large datasets, facilitate collaboration from a distance, and avail complex chemoinformatics tools without needing a large infrastructure on-site. A 2024 report by Avaahi Tech reveals that pharmaceutical companies achieve an average 30% reduction in IT operational costs by adopting cloud services, enabling more efficient and cost-effective research and operations. Cloud computing, in general, also supports easier data sharing and collaboration across disciplines, thereby furthering innovation. As cloud-based platforms continue to change, they play an increasingly vital role in accelerating research and enabling breakthroughs in drug development, particularly in high-throughput environments.

Chemoinformatics Industry Segmentation:

Analysis by Application:

  • Chemical Analysis
  • Drug Discovery
  • Drug Validation
  • Others

The chemical analysis leads with around 30.0% of the chemoinformatics market share in 2024. It plays a very crucial role in drug discovery, material science, and quality control processes. This will be essential in developing new pharmaceuticals and chemical products as it accurately identifies, characterizes, and validates compounds. With increasing molecular structure complexity, demand for analytical tools and software will continue to rise to obtain more accurate data. In addition, pharmaceutical, agriculture, and environmental science industries greatly rely on chemical analysis for regulation and innovation purposes. Chemical analysis is being further dominated by these elements within the scope of chemoinformatics.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2024, North America accounted for the largest market share of over 43.6%. North America is the leader in the chemoinformatics market, as it has a strong pharmaceutical and biotechnology sector, which makes significant investments in drug discovery and development. Additionally, the rising incidence of chronic diseases and the growing demand for personalized medicine are propelling research efforts. Supportive policies from the government, strong investment in healthcare innovations, and mutual collaborations between research institutions and private players are driving North America's dominance in the chemoinformatics market.

Key Regional Takeaways:

United States Chemoinformatics Market Analysis

In 2024, the United States represented 83.60% of the North America passive electronic components market, driven by continual advancements in drug discovery as well as substantial investments in the research and development of chemoinformatics solutions. The fiscal year 2023 witnessed that the U.S. federal government spent about USD 190 Billion in R&D activities, thereby helping the widespread adaptation of chemoinformatics tools in pharmaceutical as well as in academic institutions. Integration of artificial intelligence and machine learning in chemoinformatics accelerates compound screening and molecular analysis. The leaders include BIOVIA and Schrodinger, offering software platforms that are useful for drug design and material sciences. Government support, through the National Institutes of Health (NIH) funding, improves innovation, and thus propels market growth. Apart from this, the home country software development bolster adds another layer of competitive advantage to US-based companies around the globe. The United States remains the top player in chemoinformatics, building upon export opportunities and collaborative alliances to strengthen this position.

Europe Chemoinformatics Market Analysis

Europe's chemoinformatics market is moving ahead due to the strict regulations and more pharmaceutical research. Horizon Europe has also granted EUR 95.5 Billion (USD 98.92 Billion) for research programs (2021-2027), and digital tools such as chemoinformatics are used in these drug developments. Germany, France, and the UK are first in using advanced software for molecular modeling, which is primarily due to their large pharmaceutical industries. ChemAxon and Cresset are companies working on new innovations, such as predictive analytics in chemical synthesis. The market is also benefited from the EU policy of open-access platforms for research, thereby creating a bridge between academia and industry. The drive for sustainable chemistry in Europe accelerates the growth of green tools, thereby accelerating the market further.

Asia Pacific Chemoinformatics Market Analysis

The Asia Pacific market is growing with increase in pharmaceutical R&D, as well as academic collaborations. To that extent, the Chinese Ministry of Science and Technology reported that in 2022, USD 441 Billion was allocated to R&D for innovations in drug discovery and computational chemistry. India, through its "Digital India" initiative, encourages the growth of indigenous software development, chemoinformatics thereby is gradually finding footholds in education and commerce. Local startups partner with international companies to advance AI-driven solutions for drug design. Japan and South Korea are also investing in supercomputing capabilities to enhance molecular simulations. The growing demand for precision medicine in the region further supports market expansion. Government-backed initiatives, such as China's AI Pharma program, ensure that the Asia Pacific remains a key player in the global chemoinformatics landscape.

Latin America Chemoinformatics Market Analysis

Advances in the pharmaceutical sector and research initiatives are the driving factors behind the growth of the Latin American chemoinformatics market. According to an industry report, in 2023, the Brazilian chemical and pharmaceutical industry achieved a turnover of EUR 105.2 Billion (USD 116.1 Billion), showing a strong potential of the region. Companies in Brazil are increasingly implementing chemoinformatics for improved drug discovery and development. In Mexico and Argentina, research institutions are including computational tools in their programs, further increasing the demand for advanced solutions. Government incentives, including tax benefits for R&D, are driving innovation. Besides, strategic collaboration with global players gives access to cutting-edge technologies, ensuring steady market growth. Moreover, the focus on combating neglected tropical diseases positions Latin America as an emerging contributor to the global chemoinformatics landscape.

Middle East and Africa Chemoinformatics Market Analysis

The Middle East and Africa market is expanding due to their investments in health care and research. In 2022, the Saudi Arabian Ministry of Investment reports that the Kingdom allocated USD 37 Billion to healthcare, which included programs for advanced pharmaceutical technologies. A regional leader in biotech research, South Africa becomes increasingly more encompassing using chemoinformatics technologies during its drug discovery processes. International ties provide access to cutting-edge technologies through partnerships with European software developers. The government programs promoting STEM education further add to the market potential. Furthermore, the increased focus on personalized medicine across the region increases the demand for predictive modeling and molecular docking tools, making the market a sustainable growth story.

Competitive Landscape:

The market for chemoinformatics is very competitive, with major companies emphasizing on advanced software solutions and platforms with artificial intelligence, machine learning, and big data analytics for streamlining drug discovery and molecular research. Continuous innovation fuels competition, making the firms heavily invest in R&D on developing even more accurate and efficient tools for molecular modeling, cheminformatics, and predictive analytics. Strategic partnerships, collaborations with academic institutions, and acquisitions are all common in order to improve their technological abilities and broaden market reach. The increasing need for personalized medicine and a rise in chronic diseases further enhance this dynamic competitive environment. For instance, On October 21, 2024, Agilent Technologies launched the Infinity III LC Series, featuring enhanced automation, connectivity, and sustainability capabilities. The new systems, including the 1290 Infinity III LC and 1260 Infinity III Prime LC, introduce InfinityLab Assist Technology to streamline operations and minimize errors. This innovation aims to improve lab efficiency, reduce operator workload, and provide greater accuracy through automated routines and advanced sample tracking, reinforcing Agilent's leadership in liquid chromatography solutions.

The report provides a comprehensive analysis of the competitive landscape in the chemoinformatics market with detailed profiles of all major companies, including:

  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • BioSolveIT GmbH
  • BIOVIA (Dassault Systemes)
  • ChemAxon, Inc.
  • Eurofins CEREP SA (Eurofins Panlabs Inc.)
  • Jubilant Biosys Inc.
  • Molecular Discovery Ltd.
  • OpenEye Scientific Software Inc.
  • Schrodinger Inc.

Key Questions Answered in This Report

  • 1.What is chemoinformatics?
  • 2.How big is the chemoinformatics market?
  • 3.What is the expected growth rate of the global chemoinformatics market during 2025-2033?
  • 4.What are the driving factors of the chemoinformatics market?
  • 5.What is the leading segment of the global chemoinformatics market based on application?
  • 6.Which region leads the global chemoinformatics market?
  • 7.Who are the prominent players operating in the chemoinformatics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Chemoinformatics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Application

  • 6.1 Chemical Analysis
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Drug Discovery
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Drug Validation
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Region

  • 7.1 North America
    • 7.1.1 United States
      • 7.1.1.1 Market Trends
      • 7.1.1.2 Market Forecast
    • 7.1.2 Canada
      • 7.1.2.1 Market Trends
      • 7.1.2.2 Market Forecast
  • 7.2 Asia-Pacific
    • 7.2.1 China
      • 7.2.1.1 Market Trends
      • 7.2.1.2 Market Forecast
    • 7.2.2 Japan
      • 7.2.2.1 Market Trends
      • 7.2.2.2 Market Forecast
    • 7.2.3 India
      • 7.2.3.1 Market Trends
      • 7.2.3.2 Market Forecast
    • 7.2.4 South Korea
      • 7.2.4.1 Market Trends
      • 7.2.4.2 Market Forecast
    • 7.2.5 Australia
      • 7.2.5.1 Market Trends
      • 7.2.5.2 Market Forecast
    • 7.2.6 Indonesia
      • 7.2.6.1 Market Trends
      • 7.2.6.2 Market Forecast
    • 7.2.7 Others
      • 7.2.7.1 Market Trends
      • 7.2.7.2 Market Forecast
  • 7.3 Europe
    • 7.3.1 Germany
      • 7.3.1.1 Market Trends
      • 7.3.1.2 Market Forecast
    • 7.3.2 France
      • 7.3.2.1 Market Trends
      • 7.3.2.2 Market Forecast
    • 7.3.3 United Kingdom
      • 7.3.3.1 Market Trends
      • 7.3.3.2 Market Forecast
    • 7.3.4 Italy
      • 7.3.4.1 Market Trends
      • 7.3.4.2 Market Forecast
    • 7.3.5 Spain
      • 7.3.5.1 Market Trends
      • 7.3.5.2 Market Forecast
    • 7.3.6 Russia
      • 7.3.6.1 Market Trends
      • 7.3.6.2 Market Forecast
    • 7.3.7 Others
      • 7.3.7.1 Market Trends
      • 7.3.7.2 Market Forecast
  • 7.4 Latin America
    • 7.4.1 Brazil
      • 7.4.1.1 Market Trends
      • 7.4.1.2 Market Forecast
    • 7.4.2 Mexico
      • 7.4.2.1 Market Trends
      • 7.4.2.2 Market Forecast
    • 7.4.3 Others
      • 7.4.3.1 Market Trends
      • 7.4.3.2 Market Forecast
  • 7.5 Middle East and Africa
    • 7.5.1 Market Trends
    • 7.5.2 Market Breakup by Country
    • 7.5.3 Market Forecast

8 SWOT Analysis

  • 8.1 Overview
  • 8.2 Strengths
  • 8.3 Weaknesses
  • 8.4 Opportunities
  • 8.5 Threats

9 Value Chain Analysis

10 Porters Five Forces Analysis

  • 10.1 Overview
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Degree of Competition
  • 10.5 Threat of New Entrants
  • 10.6 Threat of Substitutes

11 Price Analysis

12 Competitive Landscape

  • 12.1 Market Structure
  • 12.2 Key Players
  • 12.3 Profiles of Key Players
    • 12.3.1 Agilent Technologies Inc.
      • 12.3.1.1 Company Overview
      • 12.3.1.2 Product Portfolio
      • 12.3.1.3 Financials
      • 12.3.1.4 SWOT Analysis
    • 12.3.2 Bio-Rad Laboratories Inc.
      • 12.3.2.1 Company Overview
      • 12.3.2.2 Product Portfolio
      • 12.3.2.3 Financials
      • 12.3.2.4 SWOT Analysis
    • 12.3.3 BioSolveIT GmbH
      • 12.3.3.1 Company Overview
      • 12.3.3.2 Product Portfolio
      • 12.3.3.3 Financials
    • 12.3.4 BIOVIA (Dassault Systemes)
      • 12.3.4.1 Company Overview
      • 12.3.4.2 Product Portfolio
    • 12.3.5 ChemAxon Inc.
      • 12.3.5.1 Company Overview
      • 12.3.5.2 Product Portfolio
    • 12.3.6 Eurofins CEREP SA (Eurofins Panlabs Inc.)
      • 12.3.6.1 Company Overview
      • 12.3.6.2 Product Portfolio
    • 12.3.7 Jubilant Biosys Inc.
      • 12.3.7.1 Company Overview
      • 12.3.7.2 Product Portfolio
    • 12.3.8 Molecular Discovery Ltd.
      • 12.3.8.1 Company Overview
      • 12.3.8.2 Product Portfolio
      • 12.3.8.3 Financials
    • 12.3.9 OpenEye Scientific Software Inc.
      • 12.3.9.1 Company Overview
      • 12.3.9.2 Product Portfolio
    • 12.3.10 Schrodinger Inc.
      • 12.3.10.1 Company Overview
      • 12.3.10.2 Product Portfolio
      • 12.3.10.3 Financials

List of Figures

  • Figure 1: Global: Chemoinformatics Market: Major Drivers and Challenges
  • Figure 2: Global: Chemoinformatics Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Chemoinformatics Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Chemoinformatics Market: Breakup by Application (in %), 2024
  • Figure 5: Global: Chemoinformatics Market: Breakup by Region (in %), 2024
  • Figure 6: Global: Chemoinformatics (Chemical Analysis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 7: Global: Chemoinformatics (Chemical Analysis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 8: Global: Chemoinformatics (Drug Discovery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Chemoinformatics (Drug Discovery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Chemoinformatics (Drug Validation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Chemoinformatics (Drug Validation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Chemoinformatics (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Chemoinformatics (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: North America: Chemoinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: North America: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: United States: Chemoinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: United States: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Canada: Chemoinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Canada: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Asia-Pacific: Chemoinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Asia-Pacific: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: China: Chemoinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: China: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Japan: Chemoinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Japan: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: India: Chemoinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: India: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: South Korea: Chemoinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: South Korea: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Australia: Chemoinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Australia: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Indonesia: Chemoinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Indonesia: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Others: Chemoinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Others: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Europe: Chemoinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Europe: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Germany: Chemoinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Germany: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: France: Chemoinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: France: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: United Kingdom: Chemoinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: United Kingdom: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Italy: Chemoinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Italy: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Spain: Chemoinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Spain: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Russia: Chemoinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Russia: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Others: Chemoinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Others: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Latin America: Chemoinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Latin America: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Brazil: Chemoinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Brazil: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Mexico: Chemoinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Mexico: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Others: Chemoinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Others: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Middle East and Africa: Chemoinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Middle East and Africa: Chemoinformatics Market: Breakup by Country (in %), 2024
  • Figure 62: Middle East and Africa: Chemoinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Global: Chemoinformatics Industry: SWOT Analysis
  • Figure 64: Global: Chemoinformatics Industry: Value Chain Analysis
  • Figure 65: Global: Chemoinformatics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Chemoinformatics Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Chemoinformatics Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 3: Global: Chemoinformatics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 4: Global: Chemoinformatics Market: Competitive Structure
  • Table 5: Global: Chemoinformatics Market: Key Players